Related Experiment Video
Updated: Jun 20, 2026

Laparoscopic Anatomical Resection of the Right Anterior Lobe Based on the Laennec Capsule Technique
Published on: May 2, 2025
Hepatic arterial infusion chemotherapy review
Xavier L Baldwin1, Michael I D'Angelica1
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, United States.
Hepatic artery infusion chemotherapy (HAIC) offers targeted liver cancer treatment. This review explores HAIC
Area of Science:
- Oncology
- Hepatobiliary Surgery
- Cancer Therapeutics
Background:
- Hepatic artery infusion chemotherapy (HAIC) is a liver-directed therapy.
- The hepatic artery's blood supply to liver tumors underpins HAIC's efficacy.
- Initially for unresectable colorectal liver metastasis (CRLM), HAIC's applications are expanding.
Purpose of the Study:
- To review the historical development of HAIC.
- To outline the evolution of HAIC treatment protocols.
- To discuss current applications and outcomes of HAIC in liver cancer.
Main Methods:
- Literature review of HAIC history and applications.
- Analysis of treatment evolution and patient outcomes.
- Synthesis of data on HAIC for CRLM and intrahepatic cholangiocarcinoma (ICC).
Main Results:
- HAIC has evolved from a palliative to a therapeutic option.
- Increasing adoption of HAIC programs globally.
- Emerging roles in resectable CRLM and unresectable ICC.
Conclusions:
- HAIC is a significant advancement in liver cancer therapy.
- The prevalence and application of HAIC continue to grow.
- Further research into HAIC outcomes is warranted.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
